Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2008 Jul-Aug;28(4):575-81.
doi: 10.1177/0272989X08315242. Epub 2008 Mar 31.

Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consent

Affiliations
Randomized Controlled Trial

Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consent

Kevin P Weinfurt et al. Med Decis Making. 2008 Jul-Aug.

Abstract

Background: Participants in early-phase clinical trials have reported high expectations of benefit from their participation. There is concern that participants misunderstand the trials to which they have consented, which is based on assumptions about what patients mean when responding to questions about likelihood of benefit.

Methods: Participants were 27 women and 18 men in early-phase oncology trials at 2 academic medical centers in the United States. To determine whether expectations of benefit differ depending on how patients are queried, the authors randomly assigned participants to 1 of 3 interviews corresponding to 3 questions about likelihood of benefit: frequency type, belief type, and vague. In semistructured interviews, participants were queried about how they understood and answered the question. Participants then answered and discussed 1 of the other questions.

Results: Expectations of benefit in response to the belief-type question were significantly greater than expectations in response to the frequency-type and vague questions (P=0:02). The most common justifications involved positive attitude (n=27 [60%]) and references to physical health (n=23 [51%]). References to positive attitude were most common among participants with higher (> 70%) expectations (n = 11 [85%]) and least common among those with lower ( < 50%) expectations (n = 3 [27%]).

Conclusions: The wording of questions about likelihood of benefit shapes the expectations that patients express. Patients who express high expectations may not do so to communicate understanding but rather to register optimism. Ongoing research will clarify the meaning of high expectations and examine methods for assessing understanding.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Expectations of Benefit by Question Type
The figure shows the distribution of responses to the target questions regarding likelihood of benefit (medians, interquartile ranges, and the minimum and maximum values), based on the first question given. Two participants did not answer the first target question. The responses differed significantly depending on the question type (Kruskal-Wallis chi-square [2 df] = 7.5; P = .02). Responses to the belief-type question were significantly greater than responses to the frequency-type question (P = .02) and the vague question (P = .02). Responses to the frequency-type and vague questions did not differ significantly from each other (P = .92).

References

    1. Agrawal M, Emanuel EJ. Ethics of phase 1 oncology studies: reexamining the arguments and the data. JAMA. 2003;290:1075–82. - PubMed
    1. Menikoff J. Consent forms for oncology trials. N Engl J Med. 2003;348:1496–7. - PubMed
    1. King NM, Henderson GE, Churchill LR, et al. Consent forms and the therapeutic misconception. IRB. 2005;27:1–8. - PubMed
    1. Henderson GE, Easter MM, Zimmer C, et al. Therapeutic misconception in early phase gene transfer trials. Soc Sci Med. 2006;62:239–53. - PubMed
    1. Horng S, Emanuel EJ, Wilfond B, Rackoff J, Martz K, Grady C. Descriptions of benefits and risks in consent forms for phase 1 oncology trials. N Engl J Med. 2002;347:2134–40. - PubMed

Publication types